MT-0814 / Mitsubishi Tanabe  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MT-0814 / Mitsubishi Tanabe
NCT03869684: A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Terminated
2
13
US
MT-0814, Placebo
Senju Pharmaceutical Co., Ltd., PPD
Age-related Macular Degeneration
03/20
04/20

Download Options